본문 바로가기
KERD
논문KCI 등재

만성질환 의료비 예측과 건강행동시나리오에 따른 절감 효과 분석

Prediction of Medical Expenses for Chronic Diseases and Analysis of Savings According to Health Behavior Scenarios

0

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

The rapid increase of chronic diseases caused by population aging and changes in lifestyle is proceeding all over the world. Chronic diseases are ‘lifestyle-related diseases' that require constant management and tracking. As chronic diseases increase, social and personal burdens also increase. It is essential to identify and predict the cost of chronic diseases. And It is necessary to propose a direction to move forward through the review of health promotion policies. The purpose of the study is to predict the medical expenses as well as the future prevalent population of chronic diseases. Not only this, but also the study simulates health promotion scenarios to propose the milestone to health promotion policies. Future Elderly Model(FEM) is a very useful dynamic microsimulation analysis method to predict future medical conditions(population, expenses etc.) First developed in 2004 by RAND Corp. and CMS(The Centers for Medicare & Medicaid Services), FEM was designed to investigate the medical expenses of Medicare beneficiaries. As FEM is a dynamic microsimulation model, the data should be personal level date with longitudinal design. National Health Insurance Service sample cohort DB(NHID-cohort) is a well-managed cohort database which represents total population. Based on FEM using NHID-cohort(2009~2013), we predicted the prevalent population and medical expenses for 11 chronic diseases by 2015 to 2041 in every two year. The most prevalent population increases disease is hypertension(6,932,380 increment). Chronic renal failure is the disease with the greatest rate of increase(3.68 times) in the prevalent population. The prevalence of hypertension increase(10.62) is the highest, and in 2041 it is estimated that 42.00% of the population over 40 has hypertension. The diseases with high prevalence are diabetes(18.89%), mental and behavioral disorders(18.96%), and neurological diseases(19.05%). The cost of chronic diseases in 2041 was estimated to increase by 61.68 trillion won(3.96 times) compared to 2015, to 82.52 trillion won. Disease with the largest increase in medical expense is mental and behavioral disorders with an increase of 14.76 trillion won, 4.81 times the cost of medical expenses in 2015. Cancer expense increases to 16.33 trillion won. Lastly, the effect of reducing medical expenditure reflecting changes in health status with decreasing smoking and obesity rates is simulated. If smoking rate reduction scenario is successfully implemented, the cost of 11 chronic diseases is predicted to save 15.47 billion won by 2021 and 50.71 billion won by 2041. If obesity rate reduction scenario successfully implemented, the cost of 11 chronic diseases is predicted to save 72 billion won in 2021 and 201.6 billion won in 2041. This study has significant implications for predicting the prevalent population of chronic diseases and increasing medical expenditure as social problems in Korea. It also has the potential to be used as a basic data for policy through improvement of health status through simulation.

Abstract

The rapid increase of chronic diseases caused by population aging and changes in lifestyle is proceeding all over the world. Chronic diseases are ‘lifestyle-related diseases' that require constant management and tracking. As chronic diseases increase, social and personal burdens also increase. It is essential to identify and predict the cost of chronic diseases. And It is necessary to propose a direction to move forward through the review of health promotion policies. The purpose of the study is to predict the medical expenses as well as the future prevalent population of chronic diseases. Not only this, but also the study simulates health promotion scenarios to propose the milestone to health promotion policies. Future Elderly Model(FEM) is a very useful dynamic microsimulation analysis method to predict future medical conditions(population, expenses etc.) First developed in 2004 by RAND Corp. and CMS(The Centers for Medicare & Medicaid Services), FEM was designed to investigate the medical expenses of Medicare beneficiaries. As FEM is a dynamic microsimulation model, the data should be personal level date with longitudinal design. National Health Insurance Service sample cohort DB(NHID-cohort) is a well-managed cohort database which represents total population. Based on FEM using NHID-cohort(2009~2013), we predicted the prevalent population and medical expenses for 11 chronic diseases by 2015 to 2041 in every two year. The most prevalent population increases disease is hypertension(6,932,380 increment). Chronic renal failure is the disease with the greatest rate of increase(3.68 times) in the prevalent population. The prevalence of hypertension increase(10.62) is the highest, and in 2041 it is estimated that 42.00% of the population over 40 has hypertension. The diseases with high prevalence are diabetes(18.89%), mental and behavioral disorders(18.96%), and neurological diseases(19.05%). The cost of chronic diseases in 2041 was estimated to increase by 61.68 trillion won(3.96 times) compared to 2015, to 82.52 trillion won. Disease with the largest increase in medical expense is mental and behavioral disorders with an increase of 14.76 trillion won, 4.81 times the cost of medical expenses in 2015. Cancer expense increases to 16.33 trillion won. Lastly, the effect of reducing medical expenditure reflecting changes in health status with decreasing smoking and obesity rates is simulated. If smoking rate reduction scenario is successfully implemented, the cost of 11 chronic diseases is predicted to save 15.47 billion won by 2021 and 50.71 billion won by 2041. If obesity rate reduction scenario successfully implemented, the cost of 11 chronic diseases is predicted to save 72 billion won in 2021 and 201.6 billion won in 2041. This study has significant implications for predicting the prevalent population of chronic diseases and increasing medical expenditure as social problems in Korea. It also has the potential to be used as a basic data for policy through improvement of health status through simulation.

참고문헌 (59)

  1. 강재헌, "우리나라 성인의 허혈성 심장질환, 뇌졸중으로 인한 총 진료비 중 과체중 및 비만의 기여분", 보건교육건강증진학회지, 27(4), pp.83~90 (2010), 한국보건교육건강증진학회
  2. 인구구조 변화에 따른 조세수입 전망과 사회복지 지출부담 분석, "고제이", 한국보건사회연구원, ~ (2014)
  3. 통계로 본 암 현황, "국립암센터", 보건복지부, 국립암센터, ~ (2016)
  4. 김상아, "전이함수모형을 이용한 국민의료비 예측", 보건행정학회지, 13(3), pp.91~103 (2003), 한국보건행정학회
  5. 사회보장시스템의 생애소득 재분배 연구, "김혜원", 한국노동연구원, ~ (2010)
  6. 뇌졸중임상연구센터, "뇌졸중진료지침", 뇌졸중임상연구센터, ~ (2015)
  7. 박선은, "2007년 흡연의 사회경제적 비용 추계", Korean Journal of Health Promotion, 8(4), pp.219~227 (2008), 대한임상건강증진학회
  8. 건강보험 중·장기 재정추계 모형 연구, "박승준", 국회예산정책처, ~ (2014)
  9. 백미라, "FEM을 활용한 만성질환 의료비 예측과 절감방안에 관한 연구", 박사, pp.2016
  10. 백미라, "중·고령자의 주요 만성질환 유병인구 예측: Future Elderly Model을적용", 보건정보통계학회지, 41(2), pp.212~222 (2016), 한국보건정보통계학회[DOI]
  11. 백미라, "Future Elderly Model을 활용한 중ㆍ고령자의 연령집단별 3대 만성질환 의료비 변화 예측", 보건행정학회지, 26(3), pp.185~194 (2016), 한국보건행정학회
  12. 건강보험 장기재정전망, "보건복지부", ~ (2014)
  13. 보건복지부, "제4차 국민건강증진 종합계획", 보건복지부, 한국건강증진개발원, ~ (2015)
  14. 2014년 한국의료패널 심층분석보고서, "서남규", 국민건강보험 건강보험정책연구원, ~ (2014)
  15. 안병철, "과체중-비만의 사회경제적 비용 추계", Journal of Nutrition and Health, 38(9), pp.786~792 (2005), 한국영양학회
  16. 인구동태 마이크로시뮬레이션 기술동향, "안창원", ETRI, ~ (2014)
  17. 주요 건강위험요인의 사회경제적 영향과 규제정책의 효과 평가, "이선미", 국민건강보험공단 건강보험정책연구원, ~ (2015)
  18. 고령화와 노인 의료비 연구, "이은경", 한국조세연구원, ~ (2011)
  19. 건강위해행동이 보건의료 재정에 미치는 영향, "이은경", 한국조세재정연구원, ~ (2015)
  20. 이진석, "최근의 금연정책으로 인한 흡연 관련 질병 발생 감소와 비용 절감", 박사, 의료관리학, pp.2006
  21. 생애의료비 추정 및 특성 분석, "임달오", 보건산업진흥원, ~, pp.보건산업브리프 VOL.100 (2013)
  22. 의료서비스산업의 2020비전과 전략, "정기택", 산업연구원, ~, pp.정책자료 2007-66 (2007)
  23. 비만과 흡연의 생애의료비 비교분석 및 건강증진에 따른 중장기적 효과 분석, "정영호", 한국보건사회연구원, ~ (2010)
  24. 고령자의 복합만성질환 분석 : 외래이용을 중심으로, "정영호", 한국보건사회연구원, ~ (2013)
  25. 생애의료비 추정을 통한 국민의료비 분석(Ⅰ), "정영호", 한국보건사회연구원, ~ (2009)
  26. 정영호, "암의 생애의료비 추정: 코호트 시뮬레이션 활용", 보건복지포럼 (2011)
  27. 효과적인 만성질환 관리방안 연구, "정영호", 한국보건사회연구원, ~ (2013)
  28. 국민의료비 미래추계 구축방안, "정형선", 보건복지부, 연세대학교 원주산학협력단, 한국보건사회연구원, ~ (2015)
  29. 2014년 국민보건계정, "정형선", 보건복지부, 연세대학교 의료복지연구소, 한국보건사회연구원, ~ (2016)
  30. 정형선, "건강보험 노인의료비의 증가요인분석 및 향후전망", 보건경제와 정책연구, 19(2), pp.21~38 (2013), 한국보건경제정책학회
  31. 지선하, "2012년 흡연으로 인한 건강보험 진료비 추정 연구", 보건정보통계학회지, 39(1), pp.25~41 (2014), 한국보건정보통계학회
  32. 질병관리본부 질병예방센터 건강영양조사과, "만성콩팥병 유병현황", 질병관리본부, ~ (2013)
  33. 질병관리본부, "2015 만성질환 현황과 이슈 -만성질환 Factbook-", 질병관리본부, ~ (2015)
  34. 질병관리본부, "결핵환자 신고현황 연보 2016", 질병관리본부, ~ (2016)
  35. 통계청, "장래인구추계", 통계청, ~ (2004)
  36. 통계청, "2015년 사망원인통계", 통계청, ~ (2016)
  37. 통계청, "2016 고령자 통계", 통계청, ~ (2016)
  38. 통계청, "장래인구추계: 2015-2065년", 통계청, ~ (2016)
  39. 2013년 한국의료패널 기초분석보고서(Ⅰ), "한국보건사회연구원", 한국보건사회연구원, 국민건강보험공단, ~ (2015)
  40. 2014년 한국의료패널 기초분석보고서(Ⅱ), "한국보건사회연구원", 한국보건사회연구원, 국민건강보험공단, ~ (2016)
  41. Alemayehu, B., "The lifetime distribution of health care costs", Health services research, 39(3), pp.627~642 (2004)
  42. A Comparative Analysis of Health Forecasting Methods, "Astolfi, R.", OECD, ~ (2012)
  43. Bhattacharya, J, "Technological advances in cancer and future spending by the elderly", Health Affairs, 24, pp.W5R53~ (2005)
  44. Brown, L., "New frontiers in microsimulation modelling", pp.527~556 (2009)
  45. Dekkers, G., "Micro simulation, pension adequacy and the dynamic model MIDAS: an introduction, Project AIM-Deliverable, 4", ~ (2009)
  46. Health status and medical treatment of the future elderly, "Goldman, D. P.", RAND CORP SANTA MONICA CA, ~, pp.TR-169-CMS (2004)
  47. Goldman, D. P., "Consequences of health trends and medical innovation for the future elderly", Health Affairs, 24, pp.W5R5~ (2005)
  48. Goldman, D. P., "The Future Elderly Model: Technical Documentation, New age, 51, 52", ~ (2015)
  49. Goldman, D.P., "The benefits of risk factor prevention in Americans aged 51 years and older", American Journal of Public Health, 99(11), pp.2096~2101 (2009)
  50. Goldman, D.P., "The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare", American Economic Review, 104(5), pp.230~233 (2014)
  51. Joyce, G.F., "The lifetime burden of chronic disease among the elderly", Health Affairs, 24(Suppl 2), pp.W5R18~W5R29 (2005)
  52. Lakdawalla, D. N., "The health and cost consequences of obesity among the future elderly", Health Affairs, 24, pp.W5R30~ (2005)
  53. Li, J., "A survey of dynamic microsimulation models: uses, model structure and methodology", , International Journal of Microsimulation, 6(2), pp.3~55 (2013)
  54. Michaud, P. C., "The value of medical and pharmaceutical interventions for reducing obesity", Journal of health economics, 31(4), pp.630~643 (2012)
  55. OECD, "A System of Health Accounts", OECD, ~ (2000)
  56. Orcutt, G., "A new type of socio-economic system", Review of Economics and Statistics, 58, pp.773~797 (1957)
  57. Shang, B., "Does age or life expectancy better predict health care expenditures?", Health Economics, 17(4), pp.487~501 (2008)
  58. Shekelle, P. G., "Identifying potential health care innovations for the future elderly", Health Affairs, 24, pp.W5R67~ (2005)
  59. An Aging World: 2015 International Population Reports, "Wan He", U.S. Census Bureau, ~ (2016)

관련 논문AI추천

이 간행물의 다른 논문 (5건)